![Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study - ScienceDirect Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0166354203000652-gr1.gif)
Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study - ScienceDirect
![Ulli Krieg - Immobilienfachwirt, unabhängiger Versicherungs- und Finanzmakler - info Versicherungs- und Kapitalkonzepte GmbH & Co. KG | XING Ulli Krieg - Immobilienfachwirt, unabhängiger Versicherungs- und Finanzmakler - info Versicherungs- und Kapitalkonzepte GmbH & Co. KG | XING](https://profile-images.xing.com/images/c0b08cdd9df7c6ba7911c3ad64cd8612-4/ulli-krieg.1024x1024.jpg)
Ulli Krieg - Immobilienfachwirt, unabhängiger Versicherungs- und Finanzmakler - info Versicherungs- und Kapitalkonzepte GmbH & Co. KG | XING
![Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study - ScienceDirect Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double-blind, multicentered study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0166354203000652-gr2.jpg)